Literature DB >> 17368823

Promoter analysis of human CC chemokine CCL23 gene in U937 monocytoid cells.

Yong-Hyun Shin1, Guy Wilhem Lee, Kyung-No Son, Sang Min Lee, Chang Joong Kang, Byoung S Kwon, Jiyoung Kim.   

Abstract

Expression of CCL23 is induced by external stimuli including PMA in monocytes, but its transcriptional regulation has not been studied to date. Serial deletion analysis of its 5' flanking region revealed that the region -293 to +31 was important for induction by PMA. Cis-acting elements at the -269/-264 (NFAT site), -167/-159 (NF-kappaB site), and -51/-43 (AP-1 site) positions were identified as the critical sites for the CCL23 expression in U937 cells. We demonstrated the binding of the transcription factors to the consensus sites. Specific inhibitors for signal pathways reduced PMA-induced expression of CCL23, confirming involvement of these transcription factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17368823     DOI: 10.1016/j.bbaexp.2007.01.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl.

Authors:  Mark A Gregory; Tzu L Phang; Paolo Neviani; Francesca Alvarez-Calderon; Christopher A Eide; Thomas O'Hare; Vadym Zaberezhnyy; Richard T Williams; Brian J Druker; Danilo Perrotti; James Degregori
Journal:  Cancer Cell       Date:  2010-07-13       Impact factor: 31.743

2.  Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2.

Authors:  Eliane Angst; Howard A Reber; Oscar J Hines; Guido Eibl
Journal:  Surgery       Date:  2008-06-05       Impact factor: 3.982

3.  Assembly PCR synthesis of optimally designed, compact, multi-responsive promoters suited to gene therapy application.

Authors:  H Mohamed; Y Chernajovsky; D Gould
Journal:  Sci Rep       Date:  2016-07-08       Impact factor: 4.379

4.  Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease.

Authors:  Christopher R Heier; Alyson A Fiorillo; Ellen Chaisson; Heather Gordish-Dressman; Yetrib Hathout; Jesse M Damsker; Eric P Hoffman; Laurie S Conklin
Journal:  Clin Transl Gastroenterol       Date:  2016-09-15       Impact factor: 4.488

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.